 | • レポートコード：MRC2Q12-19265 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、硫酸ネオマイシンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 硫酸ネオマイシンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 硫酸ネオマイシンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 硫酸ネオマイシンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの硫酸ネオマイシンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の硫酸ネオマイシンの売上および2028年までの予測に焦点を当てています。 硫酸ネオマイシンのグローバル主要企業には、Pfizer、Shandong Qifa、Hopebiol、Merck KGaA、Rainbowlabs、Xinyu Pharmaceutical、Maokang、Washen、Wuhan Wujing Pharmaceutical、Nuva、Henan Yide Animal Pharmaceutical、Jiangxi Huiqifeng Biotechnology、Guangzhou Pharmaceutical Group、Rxlist、Luxicaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 硫酸ネオマイシン市場は、タイプとアプリケーションによって区分されます。世界の硫酸ネオマイシン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 液体、粉末 【アプリケーション別セグメント】 医学、科学研究 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 硫酸ネオマイシン製品概要 - タイプ別市場（液体、粉末） - アプリケーション別市場（医学、科学研究） - 調査の目的 ・エグゼクティブサマリー - 世界の硫酸ネオマイシン販売量予測2017-2028 - 世界の硫酸ネオマイシン売上予測2017-2028 - 硫酸ネオマイシンの地域別販売量 - 硫酸ネオマイシンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別硫酸ネオマイシン販売量 - 主要メーカー別硫酸ネオマイシン売上 - 主要メーカー別硫酸ネオマイシン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（液体、粉末） - 硫酸ネオマイシンのタイプ別販売量 - 硫酸ネオマイシンのタイプ別売上 - 硫酸ネオマイシンのタイプ別価格 ・アプリケーション別市場規模（医学、科学研究） - 硫酸ネオマイシンのアプリケーション別販売量 - 硫酸ネオマイシンのアプリケーション別売上 - 硫酸ネオマイシンのアプリケーション別価格 ・北米市場 - 北米の硫酸ネオマイシン市場規模（タイプ別、アプリケーション別） - 主要国別の硫酸ネオマイシン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの硫酸ネオマイシン市場規模（タイプ別、アプリケーション別） - 主要国別の硫酸ネオマイシン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の硫酸ネオマイシン市場規模（タイプ別、アプリケーション別） - 主要国別の硫酸ネオマイシン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の硫酸ネオマイシン市場規模（タイプ別、アプリケーション別） - 主要国別の硫酸ネオマイシン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの硫酸ネオマイシン市場規模（タイプ別、アプリケーション別） - 主要国別の硫酸ネオマイシン市場規模（トルコ、サウジアラビア） ・企業情報 Pfizer、Shandong Qifa、Hopebiol、Merck KGaA、Rainbowlabs、Xinyu Pharmaceutical、Maokang、Washen、Wuhan Wujing Pharmaceutical、Nuva、Henan Yide Animal Pharmaceutical、Jiangxi Huiqifeng Biotechnology、Guangzhou Pharmaceutical Group、Rxlist、Luxica ・産業チェーン及び販売チャネル分析 - 硫酸ネオマイシンの産業チェーン分析 - 硫酸ネオマイシンの原材料 - 硫酸ネオマイシンの生産プロセス - 硫酸ネオマイシンの販売及びマーケティング - 硫酸ネオマイシンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 硫酸ネオマイシンの産業動向 - 硫酸ネオマイシンのマーケットドライバー - 硫酸ネオマイシンの課題 - 硫酸ネオマイシンの阻害要因 ・主な調査結果 |
An aminoglycoside antibiotic isolated from Streptomyces lavendulae (decaris), mainly containing neomycin B, with broad-spectrum antibacterial activity. Framycetin is used mostly as a topical preparation and is poorly absorbed
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Neomycin Sulphate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Neomycin Sulphate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Neomycin Sulphate is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Neomycin Sulphate include Pfizer, Shandong Qifa, Hopebiol, Merck KGaA, Rainbowlabs, Xinyu Pharmaceutical, Maokang, Washen and Wuhan Wujing Pharmaceutical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Neomycin Sulphate manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Neomycin Sulphate market. Further, it explains the major drivers and regional dynamics of the global Neomycin Sulphate market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Pfizer
Shandong Qifa
Hopebiol
Merck KGaA
Rainbowlabs
Xinyu Pharmaceutical
Maokang
Washen
Wuhan Wujing Pharmaceutical
Nuva
Henan Yide Animal Pharmaceutical
Jiangxi Huiqifeng Biotechnology
Guangzhou Pharmaceutical Group
Rxlist
Luxica
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by morphology and by application segments based on sales, price, and value for the period 2017-2028.
Neomycin Sulphate Segment by Morphology
Liquid
Powder
Neomycin Sulphate Segment by Application
Medicine
Scientific Research
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Neomycin Sulphate market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Neomycin Sulphate, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Neomycin Sulphate, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Neomycin Sulphate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neomycin Sulphate sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Neomycin Sulphate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Neomycin Sulphate sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Shandong Qifa, Hopebiol, Merck KGaA, Rainbowlabs, Xinyu Pharmaceutical, Maokang, Washen and Wuhan Wujing Pharmaceutical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Neomycin Sulphate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Neomycin Sulphate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by morphology, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by morphology, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by morphology, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by morphology, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by morphology, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neomycin Sulphate sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Neomycin Sulphate Product Introduction
1.2 Market by Morphology
1.2.1 Global Neomycin Sulphate Market Size Growth Rate by Morphology, 2017 VS 2021 VS 2028
1.2.2 Liquid
1.2.3 Powder
1.3 Market by Application
1.3.1 Global Neomycin Sulphate Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medicine
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neomycin Sulphate Sales Estimates and Forecasts 2017-2028
2.2 Global Neomycin Sulphate Revenue Estimates and Forecasts 2017-2028
2.3 Global Neomycin Sulphate Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Neomycin Sulphate Sales by Region
2.4.1 Global Neomycin Sulphate Sales by Region (2017-2022)
2.4.2 Global Sales Neomycin Sulphate by Region (2023-2028)
2.5 Global Neomycin Sulphate Revenue by Region
2.5.1 Global Neomycin Sulphate Revenue by Region (2017-2022)
2.5.2 Global Neomycin Sulphate Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Neomycin Sulphate Sales by Manufacturers
3.1.1 Global Top Neomycin Sulphate Manufacturers by Sales (2017-2022)
3.1.2 Global Neomycin Sulphate Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neomycin Sulphate in 2021
3.2 Global Neomycin Sulphate Revenue by Manufacturers
3.2.1 Global Neomycin Sulphate Revenue by Manufacturers (2017-2022)
3.2.2 Global Neomycin Sulphate Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Neomycin Sulphate Revenue in 2021
3.3 Global Neomycin Sulphate Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Neomycin Sulphate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Neomycin Sulphate Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Morphology
4.1 Global Neomycin Sulphate Sales by Morphology
4.1.1 Global Neomycin Sulphate Historical Sales by Morphology (2017-2022)
4.1.2 Global Neomycin Sulphate Forecasted Sales by Morphology (2023-2028)
4.1.3 Global Neomycin Sulphate Sales Market Share by Morphology (2017-2028)
4.2 Global Neomycin Sulphate Revenue by Morphology
4.2.1 Global Neomycin Sulphate Historical Revenue by Morphology (2017-2022)
4.2.2 Global Neomycin Sulphate Forecasted Revenue by Morphology (2023-2028)
4.2.3 Global Neomycin Sulphate Revenue Market Share by Morphology (2017-2028)
4.3 Global Neomycin Sulphate Price by Morphology
4.3.1 Global Neomycin Sulphate Price by Morphology (2017-2022)
4.3.2 Global Neomycin Sulphate Price Forecast by Morphology (2023-2028)
5 Market Size by Application
5.1 Global Neomycin Sulphate Sales by Application
5.1.1 Global Neomycin Sulphate Historical Sales by Application (2017-2022)
5.1.2 Global Neomycin Sulphate Forecasted Sales by Application (2023-2028)
5.1.3 Global Neomycin Sulphate Sales Market Share by Application (2017-2028)
5.2 Global Neomycin Sulphate Revenue by Application
5.2.1 Global Neomycin Sulphate Historical Revenue by Application (2017-2022)
5.2.2 Global Neomycin Sulphate Forecasted Revenue by Application (2023-2028)
5.2.3 Global Neomycin Sulphate Revenue Market Share by Application (2017-2028)
5.3 Global Neomycin Sulphate Price by Application
5.3.1 Global Neomycin Sulphate Price by Application (2017-2022)
5.3.2 Global Neomycin Sulphate Price Forecast by Application (2023-2028)
6 North America
6.1 North America Neomycin Sulphate Market Size by Morphology
6.1.1 North America Neomycin Sulphate Sales by Morphology (2017-2028)
6.1.2 North America Neomycin Sulphate Revenue by Morphology (2017-2028)
6.2 North America Neomycin Sulphate Market Size by Application
6.2.1 North America Neomycin Sulphate Sales by Application (2017-2028)
6.2.2 North America Neomycin Sulphate Revenue by Application (2017-2028)
6.3 North America Neomycin Sulphate Market Size by Country
6.3.1 North America Neomycin Sulphate Sales by Country (2017-2028)
6.3.2 North America Neomycin Sulphate Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Neomycin Sulphate Market Size by Morphology
7.1.1 Europe Neomycin Sulphate Sales by Morphology (2017-2028)
7.1.2 Europe Neomycin Sulphate Revenue by Morphology (2017-2028)
7.2 Europe Neomycin Sulphate Market Size by Application
7.2.1 Europe Neomycin Sulphate Sales by Application (2017-2028)
7.2.2 Europe Neomycin Sulphate Revenue by Application (2017-2028)
7.3 Europe Neomycin Sulphate Market Size by Country
7.3.1 Europe Neomycin Sulphate Sales by Country (2017-2028)
7.3.2 Europe Neomycin Sulphate Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neomycin Sulphate Market Size by Morphology
8.1.1 Asia Pacific Neomycin Sulphate Sales by Morphology (2017-2028)
8.1.2 Asia Pacific Neomycin Sulphate Revenue by Morphology (2017-2028)
8.2 Asia Pacific Neomycin Sulphate Market Size by Application
8.2.1 Asia Pacific Neomycin Sulphate Sales by Application (2017-2028)
8.2.2 Asia Pacific Neomycin Sulphate Revenue by Application (2017-2028)
8.3 Asia Pacific Neomycin Sulphate Market Size by Region
8.3.1 Asia Pacific Neomycin Sulphate Sales by Region (2017-2028)
8.3.2 Asia Pacific Neomycin Sulphate Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Neomycin Sulphate Market Size by Morphology
9.1.1 Latin America Neomycin Sulphate Sales by Morphology (2017-2028)
9.1.2 Latin America Neomycin Sulphate Revenue by Morphology (2017-2028)
9.2 Latin America Neomycin Sulphate Market Size by Application
9.2.1 Latin America Neomycin Sulphate Sales by Application (2017-2028)
9.2.2 Latin America Neomycin Sulphate Revenue by Application (2017-2028)
9.3 Latin America Neomycin Sulphate Market Size by Country
9.3.1 Latin America Neomycin Sulphate Sales by Country (2017-2028)
9.3.2 Latin America Neomycin Sulphate Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Neomycin Sulphate Market Size by Morphology
10.1.1 Middle East and Africa Neomycin Sulphate Sales by Morphology (2017-2028)
10.1.2 Middle East and Africa Neomycin Sulphate Revenue by Morphology (2017-2028)
10.2 Middle East and Africa Neomycin Sulphate Market Size by Application
10.2.1 Middle East and Africa Neomycin Sulphate Sales by Application (2017-2028)
10.2.2 Middle East and Africa Neomycin Sulphate Revenue by Application (2017-2028)
10.3 Middle East and Africa Neomycin Sulphate Market Size by Country
10.3.1 Middle East and Africa Neomycin Sulphate Sales by Country (2017-2028)
10.3.2 Middle East and Africa Neomycin Sulphate Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Shandong Qifa
11.2.1 Shandong Qifa Corporation Information
11.2.2 Shandong Qifa Overview
11.2.3 Shandong Qifa Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Shandong Qifa Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Shandong Qifa Recent Developments
11.3 Hopebiol
11.3.1 Hopebiol Corporation Information
11.3.2 Hopebiol Overview
11.3.3 Hopebiol Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Hopebiol Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hopebiol Recent Developments
11.4 Merck KGaA
11.4.1 Merck KGaA Corporation Information
11.4.2 Merck KGaA Overview
11.4.3 Merck KGaA Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck KGaA Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck KGaA Recent Developments
11.5 Rainbowlabs
11.5.1 Rainbowlabs Corporation Information
11.5.2 Rainbowlabs Overview
11.5.3 Rainbowlabs Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Rainbowlabs Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Rainbowlabs Recent Developments
11.6 Xinyu Pharmaceutical
11.6.1 Xinyu Pharmaceutical Corporation Information
11.6.2 Xinyu Pharmaceutical Overview
11.6.3 Xinyu Pharmaceutical Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Xinyu Pharmaceutical Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Xinyu Pharmaceutical Recent Developments
11.7 Maokang
11.7.1 Maokang Corporation Information
11.7.2 Maokang Overview
11.7.3 Maokang Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Maokang Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Maokang Recent Developments
11.8 Washen
11.8.1 Washen Corporation Information
11.8.2 Washen Overview
11.8.3 Washen Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Washen Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Washen Recent Developments
11.9 Wuhan Wujing Pharmaceutical
11.9.1 Wuhan Wujing Pharmaceutical Corporation Information
11.9.2 Wuhan Wujing Pharmaceutical Overview
11.9.3 Wuhan Wujing Pharmaceutical Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Wuhan Wujing Pharmaceutical Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Wuhan Wujing Pharmaceutical Recent Developments
11.10 Nuva
11.10.1 Nuva Corporation Information
11.10.2 Nuva Overview
11.10.3 Nuva Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Nuva Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nuva Recent Developments
11.11 Henan Yide Animal Pharmaceutical
11.11.1 Henan Yide Animal Pharmaceutical Corporation Information
11.11.2 Henan Yide Animal Pharmaceutical Overview
11.11.3 Henan Yide Animal Pharmaceutical Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Henan Yide Animal Pharmaceutical Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Henan Yide Animal Pharmaceutical Recent Developments
11.12 Jiangxi Huiqifeng Biotechnology
11.12.1 Jiangxi Huiqifeng Biotechnology Corporation Information
11.12.2 Jiangxi Huiqifeng Biotechnology Overview
11.12.3 Jiangxi Huiqifeng Biotechnology Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Jiangxi Huiqifeng Biotechnology Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Jiangxi Huiqifeng Biotechnology Recent Developments
11.13 Guangzhou Pharmaceutical Group
11.13.1 Guangzhou Pharmaceutical Group Corporation Information
11.13.2 Guangzhou Pharmaceutical Group Overview
11.13.3 Guangzhou Pharmaceutical Group Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Guangzhou Pharmaceutical Group Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Guangzhou Pharmaceutical Group Recent Developments
11.14 Rxlist
11.14.1 Rxlist Corporation Information
11.14.2 Rxlist Overview
11.14.3 Rxlist Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Rxlist Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Rxlist Recent Developments
11.15 Luxica
11.15.1 Luxica Corporation Information
11.15.2 Luxica Overview
11.15.3 Luxica Neomycin Sulphate Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Luxica Neomycin Sulphate Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Luxica Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neomycin Sulphate Industry Chain Analysis
12.2 Neomycin Sulphate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neomycin Sulphate Production Mode & Process
12.4 Neomycin Sulphate Sales and Marketing
12.4.1 Neomycin Sulphate Sales Channels
12.4.2 Neomycin Sulphate Distributors
12.5 Neomycin Sulphate Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Neomycin Sulphate Industry Trends
13.2 Neomycin Sulphate Market Drivers
13.3 Neomycin Sulphate Market Challenges
13.4 Neomycin Sulphate Market Restraints
14 Key Findings in The Global Neomycin Sulphate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer